Foghorn Therapeutics appoints Anna Rivkin as CBO
PremiumThe FlyFoghorn Therapeutics appoints Anna Rivkin as CBO
16d ago
iRhythm Technologies announces results of GUARD-AF trial
Premium
The Fly
iRhythm Technologies announces results of GUARD-AF trial
17d ago
Bristol announces new long-term follow-up data from Phase 3 Study of CAMZYOS
Premium
The Fly
Bristol announces new long-term follow-up data from Phase 3 Study of CAMZYOS
17d ago
Neurocrine price target raised to $189 from $177 at Jefferies
PremiumThe FlyNeurocrine price target raised to $189 from $177 at Jefferies
1M ago
Bristol Myers announces EMA validation to expand Brevanzi indication
Premium
The Fly
Bristol Myers announces EMA validation to expand Brevanzi indication
1M ago
Healthcare Stocks Rise despite Medicare Price Cuts for Their Drugs
Premium
Market News
Healthcare Stocks Rise despite Medicare Price Cuts for Their Drugs
1M ago
Prothena price target lowered to $62 from $66 at Oppenheimer
PremiumThe FlyProthena price target lowered to $62 from $66 at Oppenheimer
1M ago
Unusually active option classes on open August 13th
Premium
The Fly
Unusually active option classes on open August 13th
1M ago
Aethlon Medical receives ethics approval for clinical trial of Hemopurifier
Premium
The Fly
Aethlon Medical receives ethics approval for clinical trial of Hemopurifier
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100